These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 27916604

  • 21. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
    Wi YM, Greenwood-Quaintance KE, Schuetz AN, Ko KS, Peck KR, Song JH, Patel R.
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
    [Abstract] [Full Text] [Related]

  • 22. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
    Castanheira M, Deshpande LM, Costello A, Davies TA, Jones RN.
    J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
    [Abstract] [Full Text] [Related]

  • 23. Clonal Distribution and Its Association With the Carbapenem Resistance Mechanisms of Carbapenem-Non-Susceptible Pseudomonas aeruginosa Isolates From Korean Hospitals.
    Kim N, Ko SY, Park SY, Kim SY, Lee DE, Kwon KT, Kim YK, Lee JC.
    Ann Lab Med; 2024 Sep 01; 44(5):410-417. PubMed ID: 38433574
    [Abstract] [Full Text] [Related]

  • 24. Beta-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates.
    Fehlberg LC, Xavier DE, Peraro PP, Marra AR, Edmond MB, Gales AC.
    Microb Drug Resist; 2012 Aug 01; 18(4):402-7. PubMed ID: 22455540
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
    Hammami S, Ghozzi R, Burghoffer B, Arlet G, Redjeb S.
    Pathol Biol (Paris); 2009 Aug 01; 57(7-8):530-5. PubMed ID: 18977099
    [Abstract] [Full Text] [Related]

  • 26. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment.
    Shen JL, Fang YP.
    Genet Mol Res; 2015 Jun 18; 14(2):6723-32. PubMed ID: 26125881
    [Abstract] [Full Text] [Related]

  • 27. Carbapenem-resistant Acinetobacter baumannii from Brazil: role of carO alleles expression and blaOXA-23 gene.
    Fonseca EL, Scheidegger E, Freitas FS, Cipriano R, Vicente AC.
    BMC Microbiol; 2013 Nov 06; 13():245. PubMed ID: 24195496
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
    Gutiérrez O, Juan C, Cercenado E, Navarro F, Bouza E, Coll P, Pérez JL, Oliver A.
    Antimicrob Agents Chemother; 2007 Dec 06; 51(12):4329-35. PubMed ID: 17938181
    [Abstract] [Full Text] [Related]

  • 34. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC, Resende JA, Bastos AN, De Andrade Bastos LQ, De Andrade Bastos VQ, Bastos RV, Diniz CG, Da Silva VL.
    Microb Drug Resist; 2017 Oct 06; 23(7):852-863. PubMed ID: 28437232
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM, L'homme T, Bellulo S, Stremler N, Dubus JC, Mely L, Leroy S, Degand N, Rolain JM.
    Int J Antimicrob Agents; 2013 Sep 06; 42(3):268-71. PubMed ID: 23880169
    [Abstract] [Full Text] [Related]

  • 37. Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure.
    Meletis G, Vavatsi N, Exindari M, Protonotariou E, Sianou E, Haitoglou C, Sofianou D, Pournaras S, Diza E.
    Eur J Clin Microbiol Infect Dis; 2014 Feb 06; 33(2):253-8. PubMed ID: 24062236
    [Abstract] [Full Text] [Related]

  • 38. Carbapenem resistance mechanism and risk factors of Pseudomonas aeruginosa clinical isolates from a University Hospital in Xi'an, China.
    Zhang JF, Chen BL, Xin XY, Zhao HB, Wang HY, Song H, Xu ZK.
    Microb Drug Resist; 2009 Mar 06; 15(1):41-5. PubMed ID: 19226194
    [Abstract] [Full Text] [Related]

  • 39. Carbapenem-resistant Pseudomonas aeruginosa carrying blaVIM-36 assigned to ST308: Indicated non-virulence in a Galleria mellonella model.
    Neves PR, Perdigão Neto LV, Ruedas Martins RC, Ramos JF, Leite G, Rossi F, Sanabani SS, Rocha V, Batista MV, Guimaraes T, Levin AS, Costa SF.
    J Glob Antimicrob Resist; 2019 Mar 06; 16():92-97. PubMed ID: 30244038
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.